E

EuBiologics Co Ltd
KOSDAQ:206650

Watchlist Manager
EuBiologics Co Ltd
KOSDAQ:206650
Watchlist
Price: 11 940 KRW 0.59%
Market Cap: 436.2B KRW
Have any thoughts about
EuBiologics Co Ltd?
Write Note

EuBiologics Co Ltd
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

EuBiologics Co Ltd
Total Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
E
EuBiologics Co Ltd
KOSDAQ:206650
Total Assets
â‚©151.8B
CAGR 3-Years
-1%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Total Assets
â‚©19.9T
CAGR 3-Years
53%
CAGR 5-Years
39%
CAGR 10-Years
24%
SK Bioscience Co Ltd
KRX:302440
Total Assets
â‚©1.9T
CAGR 3-Years
49%
CAGR 5-Years
36%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Total Assets
â‚©943B
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Total Assets
â‚©640.8B
CAGR 3-Years
21%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Total Assets
â‚©299.4B
CAGR 3-Years
6%
CAGR 5-Years
33%
CAGR 10-Years
N/A
No Stocks Found

EuBiologics Co Ltd
Glance View

Market Cap
435.3B KRW
Industry
Biotechnology

EuBiologics Co., Ltd. engages in the research, development, and manufacture of biopharmaceutical products. The company is headquartered in Seoul, Seoul and currently employs 323 full-time employees. The company went IPO on 2017-01-24. The firm operates its business through two segments. The Vaccine segment manufactures and sells oral cholera vaccines. The Contract Research and Manufacturing Organization (CRMO) segment contracts, researches and manufactures biopharmaceuticals.

Intrinsic Value
17 631.48 KRW
Undervaluation 32%
Intrinsic Value
Price
E

See Also

What is EuBiologics Co Ltd's Total Assets?
Total Assets
151.8B KRW

Based on the financial report for Sep 30, 2024, EuBiologics Co Ltd's Total Assets amounts to 151.8B KRW.

What is EuBiologics Co Ltd's Total Assets growth rate?
Total Assets CAGR 5Y
12%

Over the last year, the Total Assets growth was -8%. The average annual Total Assets growth rates for EuBiologics Co Ltd have been -1% over the past three years , 12% over the past five years .

Back to Top